Trial intelligence / Profile preview

CardioSideral in Elective Heart Surgery

NCT03560687Completed

Sponsor
European Hospital
Start
Oct 2018
Primary completion
May 2020
Modality
Nanoparticles
Countries
1
01

Overview

Randomised, single-blind trial of ferric pyrophosphate in anemia (2 arms), sponsored by European Hospital. Primary endpoint: Preoperative Hemoglobin at 30 days. Started Oct 2018; status: completed.

02

Drugs

ferric pyrophosphate
03

Conditions

anemia

Beyond the preview

Go deeper on NCT03560687.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03560687.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call